Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 74Endometrial Neoplasms 10Vaginal Neoplasms 8Uterine Neoplasms 5Vulvar Neoplasms 4Neoplasms 4Radiation Injuries 3Ovarian Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Locally Advanced Cervical Cancer 2Hyperthermia 2Gynecologic Cancer 2Endometrial Clear Cell Adenocarcinoma 2Carcinoma, Ovarian Epithelial 2Anemia 2Uterine Cervical Dysplasia 1To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer 1Stage IA Uterine Sarcoma 1Sarcoma 1Prostatic Neoplasms 1Precancerous Conditions 1Papillomavirus Infections 1Locally Advanced Cervical Carcinoma 1Locally Advanced Cervical Adenocarcinoma 1Genital Neoplasms, Female 1Esophageal Neoplasms 1Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1Endometrial Adenocarcinoma 1Drug-Related Side Effects and Adverse Reactions 1Desmoplastic Small Round Cell Tumor 1

Interventions

Cisplatin 4sintilimab 2Radiation Dose Hypofractionation 1Radiation 1Platinum 1Irinotecan 1Immunotherapy 1Brachytherapy 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Cervical Carcinoma × Brachytherapy × Gynecologic × Clear all
NCT05210270 2023-01-31

HYACINCT

University of Santo Tomas Hospital, Philippines

Phase 1/2 Not yet recruiting
55 enrolled
Gynecologic

Locally Advanced Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡